Advances in Hematological Malignancies
Recent decades have witnessed remarkable progress in the domain of hematological malignancies. Novel approaches such as targeted agents, immunotherapies, and gene editing are altering the outlook for patients with blood cancers. Clinical trials continue to explore these innovative approaches, offering promise for more effective treatment options.